Dr Christopher F Smith, MD | |
5200 Dtc Pkwy, Suite 400, Greenwood Village, CO 80111-2709 | |
(303) 745-0000 | |
(303) 773-3101 |
Full Name | Dr Christopher F Smith |
---|---|
Gender | Male |
Speciality | Hospitalist |
Location | 5200 Dtc Pkwy, Greenwood Village, Colorado |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801922836 | NPI | - | NPPES |
01218486 | Medicaid | CO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 21848 (Colorado) | Primary |
207R00000X | Internal Medicine | 21848 (Colorado) | Secondary |
Entity Name | Critical Care & Pulmonary Consultants, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033135520 PECOS PAC ID: 7315851953 Enrollment ID: O20031118000100 |
News Archive
House GOP lawmakers are pushing cuts in the 2013 budget plan that go much deeper than the outline agreed upon last summer as part of a Republican-Democratic deal to raise the debt ceiling.
Individuals with severe forms of COVID-19 disease can present with compromised type I interferon (IFN) responses based on their genetics, according to results published in two papers today in the journal Science.
A study led by Robert N. Weinreb, chairman and Distinguished Professor of Ophthalmology at the University of California, San Diego School of Medicine, has received a $6.4 million, 5-year grant from the National Eye Institute, part of the National Institutes of Health, to elucidate the genetics of glaucoma in persons of African descent.
Trius Therapeutics, Inc. announced today the issuance of Patent Number 7,816,379, entitled "Oxazolidinone Derivatives," by the United States Patent and Trademark Office (USPTO). The new patent, which is exclusively licensed to Trius, protects the Company's lead investigational drug, torezolid phosphate (TR-701), currently in Phase 3 clinical testing in patients with acute bacterial skin and skin structure infections (ABSSSI).
Laboratory testing at the U.S. Centers for Disease Control and Prevention (CDC) has identified the bacteria Burkholderia pseudomallei in an aromatherapy spray -; the same type of bacteria that sickened four people in the United States earlier this year.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Christopher F Smith, MD 5200 Dtc Parkway, Suite 400, Greenwood Village, CO 80111 Ph: (303) 745-0000 | Dr Christopher F Smith, MD 5200 Dtc Pkwy, Suite 400, Greenwood Village, CO 80111-2709 Ph: (303) 745-0000 |
News Archive
House GOP lawmakers are pushing cuts in the 2013 budget plan that go much deeper than the outline agreed upon last summer as part of a Republican-Democratic deal to raise the debt ceiling.
Individuals with severe forms of COVID-19 disease can present with compromised type I interferon (IFN) responses based on their genetics, according to results published in two papers today in the journal Science.
A study led by Robert N. Weinreb, chairman and Distinguished Professor of Ophthalmology at the University of California, San Diego School of Medicine, has received a $6.4 million, 5-year grant from the National Eye Institute, part of the National Institutes of Health, to elucidate the genetics of glaucoma in persons of African descent.
Trius Therapeutics, Inc. announced today the issuance of Patent Number 7,816,379, entitled "Oxazolidinone Derivatives," by the United States Patent and Trademark Office (USPTO). The new patent, which is exclusively licensed to Trius, protects the Company's lead investigational drug, torezolid phosphate (TR-701), currently in Phase 3 clinical testing in patients with acute bacterial skin and skin structure infections (ABSSSI).
Laboratory testing at the U.S. Centers for Disease Control and Prevention (CDC) has identified the bacteria Burkholderia pseudomallei in an aromatherapy spray -; the same type of bacteria that sickened four people in the United States earlier this year.
› Verified 3 days ago
Dr. Alexandra Esther Grieb, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5200 Dtc Pkwy Ste 400, Greenwood Village, CO 80111 Phone: 303-745-0000 Fax: 303-773-3101 | |
Todd Popp, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5200 Dtc Pkwy, Suite 400, Greenwood Village, CO 80111 Phone: 303-745-0000 Fax: 303-708-1834 | |
Simi Varanasi, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5200 Dtc Pkwy Ste 400, Greenwood Village, CO 80111 Phone: 303-745-0000 Fax: 303-708-1834 | |
Jennifer O'brien, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5200 Dtc Pkwy, Suite 400, Greenwood Village, CO 80111 Phone: 303-745-0000 Fax: 303-773-3101 | |
Dr. Laura Mihaela Popescu, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 7000 E Belleview Ave Ste 209, Greenwood Village, CO 80111 Phone: 720-482-3777 Fax: 720-482-3776 | |
Paula Watts, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5200 Dtc Pkwy Ste 400, Greenwood Village, CO 80111 Phone: 303-745-0000 Fax: 303-773-3101 | |
Monet Elizabeth Meter, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5200 Dtc Pkwy Ste 400, Greenwood Village, CO 80111 Phone: 303-745-0000 |